SCHEMBL5606894

SCHEMBL5606894

BrC1C=CCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL239631 0.81
SCHEMBL852610 0.79
SCHEMBL551175 0.77
SCHEMBL551176 0.77
SCHEMBL21840695 0.75
SCHEMBL21840696 0.75
SCHEMBL21872277 0.75
SCHEMBL5909369 0.72
SCHEMBL5909368 0.72
SCHEMBL3696578 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5908692-A Ordered organic monolayers and methods of preparation thereof WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 1999-06-01 US claimed
US-4100228-A Transparent impact styrene polymer structure THE DOW CHEMICAL COMPANY (US) 1978-07-11 US claimed
US-4100227-A Transparent impact-resistant polystyrene structure THE DOW CHEMICAL COMPANY (US) 1978-07-11 US claimed
US-20260078091-A1 Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer AMGEN INC (US) 2026-03-19 US disclosed
US-20250059217-A1 HETEROCYCLIC COMPOUNDS AND METHODS OF PREPARATION THEREOF BRIGHT MINDS BIOSCIENCES INC. (CA) 2025-02-20 US disclosed
US-20240300892-A1 Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer AMGEN INC (US) 2024-09-12 US disclosed
CN-117897376-A Heterocyclic compounds and process for preparing same 光明智慧生物科学公司 2024-04-16 CN disclosed
EP-4347561-A1 HETEROCYCLIC COMPOUNDS AND METHODS OF PREPARATION THEREOF Bright Minds Biosciences Inc. (CA) 2024-04-10 EP disclosed
EP-3483143-B1 PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CANCER AMGEN INC (US) 2023-10-18 EP disclosed
CN-108368016-B Process for producing cyclopentyl alkyl ether compound 日本瑞翁株式会社 2023-09-26 CN disclosed
WO-2022246554-A1 HETEROCYCLIC COMPOUNDS AND METHODS OF PREPARATION THEREOF BRIGHT MINDS BIOSCIENCES INC. (CA) 2022-12-01 WO disclosed
EP-0297620-A2 Process for the preparation of byciclic aminocarboxylic acids, intermediates for this process and their use HOECHST AKTIENGESELLSCHAFT (DE) 1989-01-04 EP disclosed
US-4709052-A FUNGICIDES SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1987-11-24 US disclosed
EP-0128006-A2 A soil-disease-controlling agent SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1984-12-12 EP disclosed
EP-0000555-B1 PROCESS FOR THE PREPARATION OF OXIRANES SUBSTITUTED BY HALOGEN ALKYL BAYER AG (DE) 1982-02-10 EP disclosed
US-4175137-A Etherified cycloalkanols CIBA-GEIGY CORPORATION (US) 1979-11-20 US disclosed
EP-0000554-A1 Process for the preparation of oxiranes substituted by halogen alkyl BAYER AG (DE) 1979-02-07 EP disclosed
US-4100227-A Transparent impact-resistant polystyrene structure THE DOW CHEMICAL COMPANY (US) 1978-07-11 US disclosed
US-4100228-A Transparent impact styrene polymer structure THE DOW CHEMICAL COMPANY (US) 1978-07-11 US disclosed
US-4031300-A High molecular weight, high unsaturation isobutylene-cyclopentadiene copolymers EXXON RESEARCH AND ENGINEERING COMPANY (US) 1977-06-21 US disclosed